Phase II Trial of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness

NASuspendedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Chronic PainAnxietyDepressionSleeplessness
Interventions
DEVICE

Nu-V3

The Nu-V3 device provides a continuous flow of intermittent, low frequency electrical pulses to the ear's specific cranial nerve endings. This treatment is delivered 24 hours a day for the first 12 weeks, then is delivered two weeks on, one week off for the following 12 weeks.

Trial Locations (2)

46143

EZ Clinic, Greenwood

60195

Greater Chicago Specialty Physicians (GCSP) - Schamuburg, Schaumburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nu-Life Solutions

INDUSTRY